Certified by Founder
Lodge
Apnimed
start up
United States
- Cambridge, Massachusetts
- 04/05/2022
- Series C
- $62,500,000
Apnimed is a clinical-stage company advancing oral medicines to treat Obstructive Sleep Apnea and related disorders.
- Industry Pharmaceuticals
- Website https://apnimed.com/
- LinkedIn https://www.linkedin.com/company/apnimed/about/
Beacon Software | $250,000,000 | (Nov 5, 2025)
Downstream | $8,000,000 | (Nov 5, 2025)
Ruli | $6,000,000 | (Nov 5, 2025)
Mine Vision Systems | $12,500,000 | (Nov 5, 2025)
Planbase (YC S24) | $2,100,000 | (Nov 5, 2025)
The EVERY Company | $55,000,000 | (Nov 5, 2025)
Daylight Security | $33,000,000 | (Nov 5, 2025)
Azalea Therapeutics | $82,000,000 | (Nov 5, 2025)
Parable | $11,000,000 | (Nov 5, 2025)
Sunflower Labs | $16,000,000 | (Nov 5, 2025)
C.Scale | $2,000,000 | (Nov 5, 2025)
Portal26 | $9,000,000 | (Nov 5, 2025)